Litigation Details for In Re: Actos Direct Purchaser Antitrust Litigation (S.D.N.Y. 2015)

✉ Email this page to a colleague

Docket	⤷ Start Trial	Date Filed	2015-04-27
Court	District Court, S.D. New York	Date Terminated
Cause	15:1 Antitrust Litigation (Monopolizing Trade)	Assigned To
Jury Demand	Plaintiff	Referred To
Patents	6,150,383; 6,150,384; 6,166,042; 6,166,043; 6,172,090; 6,211,205; 6,271,243; 6,303,640; 6,329,404
Link to Docket	External link to docket

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2015-04-27				External link to document
2015-04-27	1		Patent No. Issue Date Patent Expiry 6,150,383 (the…its patent information that the two patents—United States Patent Nos. 5,965,584 (the “’584 Patent”) and…manufacturer’s patents and patent information for accuracy or trustworthiness. In listing patents and patent information…the ’777 Patent, the ’584 Patent, and the ’404 Patent, Takeda submitted eight other patents to the FDA…the ’584 Patent and the ’404 Patent as drug product patents claiming ACTOS only if the patents in fact	External link to document
2015-04-27	131	Memorandum & Opinion	two other patents-U.S. Patent Nos. 5,965,584 (the "'584 patent") and 6,329,404 (the "… several patents related to its diabetes medicines. The first of those patents, U.S. Patent. No. 4,687,777…hereinafter, "the Patents") as both drug product patents and method-of-use patents-and improperly … Normally, inventors obtain patents for their brand-name drugs. Patents that protect a drug may include…such patents must be submitted with an NDA is at the heart of this case. For each patent that	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Error:Operation timed out after 1005 milliseconds with 0 bytes received